Treatment of chronic mucocutaneous candidiasis with leucocytes from HL-A compatible sibling

Comparative analysis of the outcomes of elective abdominal aortic aneurysm repair in England and Sweden.

The British journal of surgery·2018

Expansion rate of descending thoracic aortic aneurysms.

The British journal of surgery·2016

Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm.

The British journal of surgery·2016

The Endovascular Sealing Device in Combination with Parallel Grafts for Treatment of Juxta/Suprarenal Abdominal Aortic Aneurysms: Short-term Results of a Novel Alternative.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016

Preoperative morphology influences thoracic aortic aneurysm sac expansion after endovascular repair.

The British journal of surgery·2016

Systematic Review of the Growth Rates and Influencing Factors in Thoracic Aortic Aneurysms.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

A Novel BORCS5 Loss-Of-Function Variant in a Patient With a Rare Neurodevelopmental Disorder.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2026

Treatment Patterns and Survival Outcomes of Head and Neck Merkel Cell Carcinoma: An Age-Stratified Analysis.

Head & neck·2026

Liquid biopsy in head and neck tumors: novel approaches and clinical applications.

Clinica chimica acta; international journal of clinical chemistry·2026

An epigenetic program dictates MYC amplification dynamics that promote transient, extrachromosomal, and inherited genomic events.

Molecular cell·2026

Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma.

Blood advances·2026

Click chemistry ligation-initiated bisulfite-free assay on nanobeads for highly sensitive detection of site-specific 5 mC.

Talanta·2026

Related Experiment Videos

Treatment of chronic mucocutaneous candidiasis with leucocytes from HL-A compatible sibling

Related Concept Videos

Comparative analysis of the outcomes of elective abdominal aortic aneurysm repair in England and Sweden.

Expansion rate of descending thoracic aortic aneurysms.

Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm.

The Endovascular Sealing Device in Combination with Parallel Grafts for Treatment of Juxta/Suprarenal Abdominal Aortic Aneurysms: Short-term Results of a Novel Alternative.

Preoperative morphology influences thoracic aortic aneurysm sac expansion after endovascular repair.

Systematic Review of the Growth Rates and Influencing Factors in Thoracic Aortic Aneurysms.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

A Novel BORCS5 Loss-Of-Function Variant in a Patient With a Rare Neurodevelopmental Disorder.

Treatment Patterns and Survival Outcomes of Head and Neck Merkel Cell Carcinoma: An Age-Stratified Analysis.

Liquid biopsy in head and neck tumors: novel approaches and clinical applications.

An epigenetic program dictates MYC amplification dynamics that promote transient, extrachromosomal, and inherited genomic events.

Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma.

Click chemistry ligation-initiated bisulfite-free assay on nanobeads for highly sensitive detection of site-specific 5 mC.

Related Experiment Videos

Treatment of chronic mucocutaneous candidiasis with leucocytes from HL-A compatible sibling

Related Concept Videos

Related Articles